Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium

Acta Microbiologica et Immunologica Hungarica

Volumn 58, Issue 3, 2011, Pages 219-226

  Aligholi, Marzieh ^a   Emaneini, Mohammad ^a   Taherikalani, Morovat ^b   Shahsavan, Shadi ^a   Jabalameli, Fereshteh ^a   Asadollahi, Parisa ^b   Khoramian, Babak ^a   Eslampour, Mohammad Amin ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

antimicrobial synergy; enterococci; time kill; VRE; VSE

Indexed keywords

AMPICILLIN; GENTAMICIN; LINEZOLID; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 80054078877     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.58.2011.3.5     Document Type: Article

References (24)

1. Cetinkaya, Y., Falk, P., Mayhall, C. G.: Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13, 686-707 (2000).
2. Emaneini, M., Hashemi, F. B., Aligholi, M., Fatholahzadeh, B., Kazemi, B., Sadeghi, F.: Detection of vanB genotype enterococci in Iran. Int. J. Antimicrob. Agents 26, 98-99 (2005). (Pubitemid 40854128)
3. Emaneini, M., Aligholi, M., Aminshahi, M.: Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran. Pol. J. Microbiol. 57, 173-178 (2008).
4. Jabalameli, F., Emaneini, M., Shahsavan, S., Sedaghat, H., Abdolmaliki, Z., Aligholi, M.: Evaluation of antimicrobial susceptibility patterns of Enterococci isolated from patients in Tehran University of Medical Sciences Teaching Hospitals. Acta Medica Iranica 47, 325-328 (2009).
5. Gould, I. M., Milne, K.: In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. J. Antimicrob. Chemother. 39, 53-61 (1997). (Pubitemid 27092270)
6. Babalola, C. P., Patel, K. B., Nightingale, C. H., Nicolau, D. P.: Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities. Int. J. Antimicrob. Agents 23, 343-348 (2004). (Pubitemid 38481545)
7. Forbes, B. A., Sahm, D. F., Weisfeld, A.: Catalase Negative Gram Positive Cocci. Baily and Scott's Diagnostic Microbiology. 10th ed. Mosby Inc., St. Louis, MI, USA, 1998, pp. 620-635.
8. Fatholahzadeh, B., Hashemi, F. B., Emaneini, M., Aligholi, M., Nakhjavani, F. A., Kazemi, B.: Detection of Vancomycin Resistant Enterococci (VRE) isolated from urinary tract infections (UTI) in Tehran, Iran. Daru 14, 141-145 (2006). (Pubitemid 44808348)
9. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. CLSI, Wayne, PA, 2004.
10. Hoellman, D. B., Visalli, M. A., Jacobs, M. R., Appelbaum, P. C.: Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis. Antimicrob. Agents Chemother. 42, 857-861 (1998). (Pubitemid 28216367)
11. Vakulenko, S. B., Donabedian, S. M., Voskresenskiy, A. M., Zervos, M. J., Lerner, S. A., Chow, J. W.: Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob. Agents Chemother. 47, 1423-1426 (2003). (Pubitemid 36368610)
12. Dutka-Malen, S., Evers, S., Courvalin, P.: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant Enterococci by PCR. J. Clin. Microbiol. 33, 24-27 (1995). (Pubitemid 24382391)
13. Emaneini, M., Taherikalani, M., Eslampour, M. A., Sedaghat, H., Aligholi, M., Jabalameli, F. et al.: Phenotypic and genotypic evaluation of aminoglycoside resistance in clinical isolates of staphylococci in Tehran, Iran. Microb. Drug Resist. 15, 129-132 (2009).
14. Courvalin, P.: Resistance of enterococci to glycopeptides. Antimicrob. Agents Chemother. 34, 2291-2296 (1990).
15. Rice, L. B., Shlaes, D. M.: Vancomycin resistance in the Enterococcus. Relevance in pediatrics. Pediatr. Clin. North. Am. 42, 601-618 (1995).
16. Chow, J. W., Donabedian, S. M., Clewell, D. B., Sahm, D. F., Zervos, M. J.: In vitro susceptibility and molecular analysis of gentamicin-resistant Enterococci. Diagn. Microbiol. Infect. Dis. 32, 141-146 (1998). (Pubitemid 29017732)
17. Tsukayama, D. T., Wichlund, B., Gruniger, R. P.: Enterococcus faecium resistant to ampicillin and gentamicin. Int. J. Antimicrob. Agents 1, 239-243 (1992).
18. Hayden, M., Koenig, G. I., Trenholme, G. M.: Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrob. Agents Chemother. 38, 1225-1229 (1994). (Pubitemid 24170699)
19. Allen, A. P., Cha, R., Rybak, M. J.: In vitro activities of quinupristin dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 46, 2602-2612 (2002).
20. Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E. et al.: In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agent. Antimicrob. Agents Chemother. 40, 839-845 (1996). (Pubitemid 26117523)
21. Clemett, D., Markham, A.: Linezolid. Drugs 59, 815-827 (2000). (Pubitemid 30232322)
22. Calderwood, S. B., Wennersten, C., Moellering, R. C.: Resistance to antibiotic synergism in Streptococcus faecalis: Further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin. Antimicrob. Agents Chemother. 19, 549-555 (1981). (Pubitemid 11079457)
23. Krogstad, D. J., Korfhagen, R. R., Moellering, R. C., Wennersten, C., Swartz, M. N.: Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis: An explanation for antibiotic synergism. J. Clin. Invest. 62, 480-486 (1978). (Pubitemid 8393318)
24. Leclercq, R., Dutka-Malen, S., Brisson-Noel, A., Molinas, C., Derlot, E., Arthur, M. et al.: Resistance of enterococci to aminoglycosides and glycopeptides. Clin. Infect. Dis. 15, 495-501(1992).